Elekta-Synergy

July 19, 2010 – Elekta will showcase its broad array of intelligent solutions for radiation therapy planning, oncology information management and image guided radiation therapy this week at the 2010 American Association of Physicists in Medicine (AAPM) Annual Meeting.

Elekta will also be demonstrating Clarity T, the latest addition to the Elekta product portfolio. Clarity provides non-invasive soft tissue visualization to support radiation therapy workflows. Using latest generation 3-D ultrasound specifically designed for radiation therapy, Clarity compares 3-D structures—not images—to provide accurate guidance non-invasively, without additional dose or any compromise to throughput.

Representing the latest advance in 4-D image guidance, Elekta’s XVI now offers intelligent motion management and guidance. Symmetry T motion management provides imaging tools to manage shifts in the relative positions of the tumor and organs-at-risk during the respiratory cycle. Intuity T provides critical structure avoidance by accounting more accurately for both the position of the tumor and the healthy critical structures.

Elekta also will show the new version of Atlas-based Auto-segmentation (ABAS) 2.0 software, which includes the Simultaneous Truth and Performance Level Estimation (STAPLE) algorithm to increase segmentation accuracy. ABAS deforms atlases of anatomy previously defined on a reference image onto a new patient image, creating a new structure set fit to the patient anatomy and enhancing planning efficiency.

Intelligent planning for Elekta VMAT is also available through Monaco with VMAT, which helps clinicians plan around structures effectively for Elekta VMAT delivery and predict the total dose the patient will receive.

To streamline the entire medical oncology or radiation oncology workflow, Elekta offers the MOSAIQ oncology information system. Through its image-enabled electronic medical record (EMR), MOSAIQ helps centers coordinate information management involving diagnosis and staging, planning, treatment and follow-up.


Related Content

News | Breast Imaging

September 27, 2023 — Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two ...

Time September 27, 2023
arrow
Feature | ASTRO | By Christine Book

September 26, 2023 — Ahead of the 65th American Society for Radiation Oncology Annual Meeting, ASTRO 2023, ITN’s ...

Time September 26, 2023
arrow
News | Prostate Cancer

September 22, 2023 — According to an accepted manuscript published in the American Journal of Roentgenology (AJR) ...

Time September 22, 2023
arrow
Feature | Radiation Oncology

The radiation oncology community lost a leader this past summer, with the passing of Jay Loeffler, MD, FACR, FASTRO. He ...

Time September 21, 2023
arrow
Feature | Proton Therapy | By Christine Book

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
arrow
News | Radiation Therapy

September 20, 2023 — RefleXion Medical, Inc., a therapeutic oncology company and 3B Pharmaceuticals (3BP) GmbH, a ...

Time September 20, 2023
arrow
News | Radiation Oncology

September 6, 2023 — Nina D’Abreo, MD, has been named as chief of the Division of Hematology and Medical Oncology at NYU ...

Time September 06, 2023
arrow
News | Radiation Oncology

August 30, 2023 — Elekta and the IAEA have signed a partnership agreement to jointly pursue common interests, including ...

Time August 30, 2023
arrow
News | Radiopharmaceuticals and Tracers

August 28, 2023 — TerraPower Isotopes and PanTera, the Belgian joint venture created by SCK CEN and IBA, announced that ...

Time August 28, 2023
arrow
News | Radiology Business

July 27, 2023 — Privately-held biotech company TAE Life Sciences has announced that its board of directors has appointed ...

Time July 27, 2023
arrow
Subscribe Now